Your browser doesn't support javascript.
loading
Age-specific ovarian cancer risks among women with a BRCA1 or BRCA2 mutation.
Kotsopoulos, Joanne; Gronwald, Jacek; Karlan, Beth; Rosen, Barry; Huzarski, Tomasz; Moller, Pal; Lynch, Henry T; Singer, Christian F; Senter, Leigha; Neuhausen, Susan L; Tung, Nadine; Eisen, Andrea; Foulkes, William D; Ainsworth, Peter; Sun, Ping; Lubinski, Jan; Narod, Steven A.
Afiliação
  • Kotsopoulos J; Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
  • Gronwald J; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
  • Karlan B; Women's Cancer Program, Cedars Sinai Medical Center, Los Angeles, CA, USA.
  • Rosen B; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Toronto, ON, Canada.
  • Huzarski T; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
  • Moller P; Inherited Cancer Research Group, The Norwegian Radium Hospital, Department for Medical Genetics; and Department of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
  • Lynch HT; Department of Preventive Medicine and Public Health, Creighton University School of Medicine, Omaha, NE, USA.
  • Singer CF; Department of Obstetrics and Gynecology and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Senter L; Division of Human Genetics, the Ohio State University Medical Center, Comprehensive Cancer Center, Columbus, OH, USA.
  • Neuhausen SL; Division of Biomarkers of Early Detection and Prevention, Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, USA.
  • Tung N; Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Eisen A; Toronto-Sunnybrook Regional Cancer Center, Toronto, ON, Canada.
  • Foulkes WD; Program in Cancer Genetics, Department of Oncology and Human Genetics, McGill University, Montréal, QC, Canada.
  • Ainsworth P; London Health Sciences, London, ON, Canada.
  • Sun P; Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada.
  • Lubinski J; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
  • Narod SA; Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada. Electronic address: steven.narod@wchospital.ca.
Gynecol Oncol ; 150(1): 85-91, 2018 07.
Article em En | MEDLINE | ID: mdl-29793803
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 6_endocrine_disorders / 6_ovary_cancer Assunto principal: Neoplasias Ovarianas / Proteína BRCA1 / Proteína BRCA2 / Mutação Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 6_endocrine_disorders / 6_ovary_cancer Assunto principal: Neoplasias Ovarianas / Proteína BRCA1 / Proteína BRCA2 / Mutação Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Canadá